Preparation of his-tagged armored RNA phage particles as a control for real-time reverse transcription-PCR detection of severe acute respiratory syndrome coronavirus

Journal of Clinical Microbiology

Volumn 44, Issue 10, 2006, Pages 3557-3561

  Cheng, Yangjian ^a   Niu, Jianjun ^b   Zhang, Yongyou ^a   Huang, Jianwei ^b   Li, Qingge ^a,c  

^a XIAMEN UNIVERSITY   (China)

^b Xiamen Center for Disease Control and Prevention   (China)

^c Key Laboratory of Biomedical Engineering of Fujian   (China)

Author keywords

[No Author keywords available]

Indexed keywords

POLYHISTIDINE TAG; HISTIDINE; VIRUS RNA;

AFFINITY CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE TARGETING; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA PHAGE; SARS CORONAVIRUS; VIRUS DETECTION; CHEMISTRY; ISOLATION AND PURIFICATION; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

RNA VIRUSES; SARS CORONAVIRUS;

HISTIDINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PHAGES; RNA, VIRAL; SARS VIRUS; SENSITIVITY AND SPECIFICITY;

EID: 34248677840     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00713-06     Document Type: Article

References (26)

1. Barkham, T. 2004. Internal amplification control for PCR should not be mandatory in the clinical medical environment. J. Clin. Microbiol. 42:3379-3380.
2. Beld, M., R. Minnaar, J. Weel, C. Sol, M. Damen, H. van der Avoort, P. Wertheim-van Dillen, A. van Breda, and R. Boom. 2004. Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control. J. Clin. Microbiol. 42:3059-3064.
3. Bressler, A. M., and F. S. Nolte. 2004. Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus. J. Clin. Microbiol. 42:987-991.
4. Brown, D., and B. L. Pasloske. 2001. Ribonuclease-resistant RNA controls and standards. Methods Enzymol. 341:648-654.
5. Burkardt, H. J. 2000. Standardization and quality control of PCR analyses. Clin. Chem. Lab. Med. 38:87-91.
6. Cartwright, C. P. 1999. Synthetic viral particles promise to be valuable in the standardization of molecular diagnostic assays for hepatitis C virus. Clin. Chem. 45:2057-2059.
7. Dreier, J., M. Stormer, and K. Kleesiek. 2005. Use of bacteriophage MS2 as an internal control in viral reverse transcription-PCR assays. J. Clin. Microbiol. 43:4551-4557.
8. Drosten, C., E. Seifried, and W. K. Roth. 2001. TaqMan 5′-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening. J. Clin. Microbiol. 39:4302-4308.
9. Eisler, D. L., A. McNabb, D. R. Jorgensen, and J. L. Isaac-Renton. 2004. Use of an internal positive control in a multiplex reverse transcription-PCR to detect West Nile virus RNA in mosquito pools. J. Clin. Microbiol. 42:841-843.
10. Gaberc-Porekar, V., and V. Menart. 2001. Perspectives of immobilized-metal affinity chromatography. J. Biochem. Biophys. Methods 49:335-360.
11. Heal, K. G., H. R. Hill, P. G. Stockley, M. R. Hollingdale, and A. W. Taylor-Robinson. 1999. Expression and immunogenicity of a liver stage malaria epitope presented as a foreign peptide on the surface of RNA-free MS2 bacteriophage capsids. Vaccine 18:251-258.
12. Hoorfar, J., N. Cook, B. Malorny, et al. 2004. Diagnostic PCR: making internal amplification control mandatory. J. Appl. Microbiol. 96:221-222.
13. Hoorfar, J., B. Malorny, A. Abdulmawjood, N. Cook, M. Wagner, and P. Fach. 2004. Practical considerations in design of internal amplification controls for diagnostic PCR assays. J. Clin. Microbiol. 42:1863-1868.
14. Konnick, E. Q., S. M. Williams, E. R. Ashwood, and D. R. Hillyard. 2005. Evaluation of the COBAS hepatitis C virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays. J. Clin. Microbiol. 43:2133-2140.
15. Liang, M. H., D. R. Johnson, and L. J. Wong. 1998. Preparation and validation of PCR-generated positive controls for diagnostic dot blotting. Clin. Chem. 44:1578-1579.
16. Lion, T. 2001. Current recommendations for positive controls in RT-PCR assays. Leukemia 15:1033-1037.
17. Mastico, R. A., S. J. Talbot, and P. G. Stockley. 1993. Multiple presentation of foreign peptides on the surface of an RNA-free spherical bacteriophage capsid. J. Gen. Virol. 74:541-548.
18. Pasloske, B. L., D. B. DuBois, D. M. Brown, and M. M. Winkler. June 2002. Methods of quantifying viral load in an animal with a ribonuclease resistant RNA preparation. U.S. patent 6,399,307.
19. Pasloske, B. L., C. R. WalkerPeach, R. D. Obermoeller, M. Winkler, and D. B. DuBois. 1998. Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards. J. Clin. Microbiol. 36:3590-3594.
20. Peabody, D. S. 2003. A viral platform for chemical modification and multivalent display. J. Nanobiotechnol. 1:5.
21. Reiss, R. A., and B. Rutz. 1999. Quality control PCR: a method for detecting inhibitors of Taq DNA polymerase. BioTechniques 27:920-926.
22. Reference deleted.
23. Stocher, M., and J. Berg. 2004. Internal control DNA for PCR assays introduced into lambda phage particles exhibits nuclease resistance. Clin. Chem. 50:2163-2166.
24. Stockley, P. G., and R. A. Mastico. 2000. Use of fusions to viral coat proteins as antigenic carriers for vaccine development. Methods Enzymol. 326:551-569.
25. WalkerPeach, C. R., M. Winkler, D. B. DuBois, and B. L. Pasloske. 1999. Ribonuclease-resistant RNA controls (Armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus. Clin. Chem. 45:2079-2085.
26. Willhauck, M., S. Vogel, and U. Keilholz. 1998. Internal control for quality assurance of diagnostic RT-PCR. BioTechniques 25:656-659.